# US 2025/0205196 A1 · Formulations of psilocin that have enhanced stability

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0205196 A1
- Document ID: US20250205196A1
- Status: Published application
- Kind: A1
- Application number: 18/824,317
- Filed: 2024-09-04
- Published: 2025-06-26
- Earliest claimed: 2021-03-06
- Assignees: Mind Medicine, Inc.
- Applicants: Mind Medicine, Inc.
- Inventors: Robert BARROW; Peter MACK; Stephen SCHNEIDER; Jon SCHROEDER; Gerald S. JONES, JR.
- Web page: https://patentgrep.com/patent/US20250205196A1

## CPC

- A61K 31/4045: Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A composition of psilocin that is stable including at least one agent or chemical modification that provides enhanced stability. A method making stable psilocin, by providing a formulation of psilocin including at least one agent or chemical modification that provides enhanced stability. A method of treatment of a disease or condition, by administering a composition of psilocin that is stable to an individual and treating the disease or condition.

## Claims

### Claim at position 1

1-17. (canceled)

### Claim 18

A method of treating a disease or condition, comprising:
administering to an individual a composition comprising psilocin besylate salt or psilocin lactate salt.

### Claim 19 (depends on 18)

The method of claim 18, wherein the disease or condition is an anxiety disorder, depression, headache disorder, obsessive compulsive disorder (OCD), personality disorder, stress disorder, drug disorder, addiction, pain, neurodegenerative disorder, autism spectrum disorder, eating disorder, or neurological disorder.

### Claim 20

(canceled)

### Claim 21 (depends on 18)

The method of claim 18, wherein the composition is stable.

### Claim 22 (depends on 21)

The method of claim 21, wherein stable includes being shelf-stable, being stable in cold storage, or being stable in storage under inert conditions.

### Claim 23 (depends on 18)

The method of claim 18, wherein the individual is administered a composition comprising the psilocin besylate salt.

### Claim 24 (depends on 23)

The method of claim 23, wherein the disease or condition is an anxiety disorder, depression, headache disorder, obsessive compulsive disorder (OCD), personality disorder, stress disorder, drug disorder, addiction, pain, neurodegenerative disorder, autism spectrum disorder, eating disorder, or neurological disorder.

### Claim 25 (depends on 24)

The method of claim 24, wherein the disease or condition is depression.

### Claim 26 (depends on 24)

The method of claim 24, wherein the disease or condition is an anxiety disorder.

### Claim 27 (depends on 24)

The method of claim 24, wherein the disease or condition is a stress disorder.

### Claim 28 (depends on 24)

The method of claim 24, wherein the disease or condition is pain.

### Claim 29 (depends on 24)

The method of claim 24, wherein the disease or condition is obsessive compulsive disorder (OCD).

### Claim 30 (depends on 24)

The method of claim 24, wherein the disease or condition is drug disorder, addiction, eating disorder, headache disorder, personality disorder, neurodegenerative disorder, autism spectrum disorder, or neurological disorder.

### Claim 31 (depends on 18)

The method of claim 18, wherein the individual is administered a composition comprising the psilocin lactate salt.

### Claim 32 (depends on 31)

The method of claim 31, wherein the disease or condition is an anxiety disorder, depression, headache disorder, obsessive compulsive disorder (OCD), personality disorder, stress disorder, drug disorder, addiction, pain, neurodegenerative disorder, autism spectrum disorder, eating disorder, or neurological disorder.

### Claim 33 (depends on 32)

The method of claim 32, wherein the disease or condition is depression.

### Claim 34 (depends on 32)

The method of claim 32, wherein the disease or condition is an anxiety disorder.

### Claim 35 (depends on 32)

The method of claim 32, wherein the disease or condition is a stress disorder.

### Claim 36 (depends on 32)

The method of claim 32, wherein the disease or condition is pain.

### Claim 37 (depends on 32)

The method of claim 32, wherein the disease or condition is obsessive compulsive disorder (OCD).

### Claim 38 (depends on 32)

The method of claim 32, wherein the disease or condition is drug disorder, addiction, eating disorder, headache disorder, personality disorder, neurodegenerative disorder, autism spectrum disorder, or neurological disorder.
